Get the Stockscreener App
20.95
1.83%
-0.39
After Hours:
20.95
Amphastar Pharmaceuticals Inc stock is traded at $20.95, with a volume of 545.00K.
It is down -1.83% in the last 24 hours and down -8.75% over the past month.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
See More
Previous Close:
$21.34
Open:
$21.06
24h Volume:
545.00K
Relative Volume:
1.08
Market Cap:
$987.56M
Revenue:
$723.55M
Net Income/Loss:
$157.72M
P/E Ratio:
6.9833
EPS:
3
Net Cash Flow:
$170.15M
1W Performance:
-6.93%
1M Performance:
-8.75%
6M Performance:
-39.92%
1Y Performance:
-51.86%
1-Day Range:
$20.77
$21.33
1-Week Range:
$20.77
$22.90
52-Week Range:
$20.43
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Name
Amphastar Pharmaceuticals Inc
Sector
Phone
909-980-9484
Address
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Compare AMPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
20.95 | 1.01B | 723.55M | 157.72M | 170.15M | 3.00 |
|
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-12-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-04-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-22-24 | Initiated | Wells Fargo | Equal Weight |
| Mar-05-24 | Initiated | JP Morgan | Overweight |
| Nov-17-23 | Initiated | BofA Securities | Neutral |
| Jul-25-23 | Resumed | Jefferies | Buy |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Jul-29-22 | Initiated | CapitalOne | Overweight |
| Jan-07-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-08-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-05-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| May-01-20 | Initiated | Northland Capital | Outperform |
| Mar-13-19 | Downgrade | Needham | Buy → Hold |
| Mar-13-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-10-18 | Reiterated | Needham | Buy |
| Mar-13-18 | Reiterated | Needham | Buy |
| Dec-01-17 | Reiterated | Needham | Buy |
| Nov-09-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-27-17 | Reiterated | Needham | Buy |
| Mar-14-17 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-09-16 | Reiterated | Needham | Buy |
| May-10-16 | Reiterated | Needham | Buy |
| Feb-19-16 | Initiated | Wells Fargo | Outperform |
| Jun-19-15 | Reiterated | Needham | Buy |
| Jun-03-15 | Initiated | Raymond James | Strong Buy |
| Jul-21-14 | Initiated | Needham | Buy |
View All
Amphastar Pharmaceuticals Inc Stock (AMPH) Latest News
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Amphastar Pharmaceuticals (AMPH) Expected to Announce Earnings on Wednesday - MarketBeat
GSA Capital Partners LLP Grows Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
How many analysts rate Amphastar Pharmaceuticals Inc. as a “Buy”Financial News Target Finder That Work - jammulinksnews.com
Amphastar Pharmaceuticals Inc. stock prediction for this weekROI Boosting Trade Opportunity Calendar Published - metal.it
Pacer Advisors Inc. Has $13.90 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Screener Results Flag Amphastar Pharmaceuticals Inc. as OversoldEntry Alert Based on Volume Spikes Detected - metal.it
Amphastar Pharmaceuticals: Shares Are Interesting, And Options Even More (NASDAQ:AMPH) - Seeking Alpha
Victory Capital Management Inc. Acquires 17,700 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Q1 Earnings Highlights: Amneal, ANI, Amphastar, and ViatrisNews and Statistics - IndexBox
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025 - ACCESS Newswire
Amphastar Pharmaceuticals Schedules Q2 Earnings: Key Financial Results Coming August 7 - Stock Titan
Legato Capital Management LLC Purchases 11,238 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Is it the right time to buy Amphastar Pharmaceuticals Inc. stockSmart Portfolio Data Feed For 2025 - jammulinksnews.com
Lidocaine Vial Market Set to Witness Significant Growth by 2033 | - openPR.com
Royce & Associates LP Raises Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Published on: 2025-07-28 17:34:56 - metal.it
When is Amphastar Pharmaceuticals Inc. stock expected to show significant growthConsistent double returns - jammulinksnews.com
Published on: 2025-07-28 16:16:47 - metal.it
What are Amphastar Pharmaceuticals Inc. company’s key revenue driversCapitalize on market momentum for maximum gains - jammulinksnews.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by TD Asset Management Inc - MarketBeat
What is Amphastar Pharmaceuticals Inc. company’s growth strategyUnlock powerful stock screening for profits - jammulinksnews.com
Should I hold or sell Amphastar Pharmaceuticals Inc. stock in 2025High-return market picks - jammulinksnews.com
Does Amphastar Pharmaceuticals Inc. stock perform well during market downturnsUnprecedented market success - jammulinksnews.com
New York State Common Retirement Fund Grows Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
What analysts say about Amphastar Pharmaceuticals Inc. stock outlookRecord-setting profit potential - jammulinksnews.com
What risks could impact Amphastar Pharmaceuticals Inc. stock performanceSkyrocketing investment returns - jammulinksnews.com
What drives Amphastar Pharmaceuticals Inc. stock priceRecord-breaking gains - PrintWeekIndia
What analysts say about Amphastar Pharmaceuticals Inc. stockHigh-yield market plays - PrintWeekIndia
Is Amphastar Pharmaceuticals (NASDAQ:AMPH) Using Too Much Debt? - 富途牛牛
Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 1-Year LowWhat's Next? - MarketBeat
Amphastar Pharmaceuticals Inc. Stock Analysis and ForecastPhenomenal capital gains - jammulinksnews.com
Fortrea, Azenta, Bio-Techne, 10x Genomics, and Amphastar Pharmaceuticals Stocks Trade Up, What You Need To Know - TradingView
What Makes Amphastar (AMPH) a New Buy Stock - Yahoo Finance
Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock? - Yahoo Finance
Here's Why Amphastar (AMPH) is Poised for a Turnaround After Losing 13.1% in 4 Weeks - Yahoo Finance
Is Amphastar Pharmaceuticals Inc. a good long term investmentFree Market Volatility Navigation Tips - jammulinksnews.com
Amphastar Pharmaceuticals Inc Stock (AMPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):